BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
17.44
-0.62 (-3.43%)
At close: Apr 28, 2026, 4:00 PM EDT
17.47
+0.03 (0.17%)
Pre-market: Apr 29, 2026, 8:37 AM EDT
BioAge Labs Revenue
In the year 2025, BioAge Labs had annual revenue of $9.00M. BioAge Labs had revenue of $3.08M in the quarter ending December 31, 2025.
Revenue (ttm)
$9.00M
Revenue Growth
n/a
P/S Ratio
86.08
Revenue / Employee
$145,081
Employees
62
Market Cap
774.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBIOA News
- 7 days ago - BioAge Labs Stock Gains After Positive Early Data And Pipeline Plans - Benzinga
- 8 days ago - BioAge Labs Transcript: Study result - Transcripts
- 8 days ago - BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP - GlobeNewsWire
- 12 days ago - BioAge Labs Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 15 days ago - BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - BioAge Labs Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 3 months ago - BioAge Announces Pricing of Upsized $115.0 Million Public Offering - GlobeNewsWire
- 3 months ago - BioAge Announces Proposed Public Offering - GlobeNewsWire